About Athna Biotech
Athna Biotech is an early-stage biotechnology company based in Athens, Georgia, dedicated to advancing innovative therapeutics from discovery to clinical translation.
Our work integrates nanomedicine, drug delivery, and translational research to develop novel therapeutic technologies addressing unmet medical needs. With expertise spanning formulation and process development, preclinical research, and IND-enabling development, we are committed to translating scientific innovation into meaningful therapeutic solutions.
Since our founding in 2019, Athna Biotech has secured over $3 million in non-dilutive funding to advance our therapeutic development programs. We continue to grow through innovation, collaboration, and a shared commitment to bringing promising science closer to patients.